SHORT MINI-FUTURE - MODERNA Stock

Certificat

DE000VU2UX38

Market Closed - Deutsche Boerse AG 01:53:46 2024-06-14 pm EDT
6.39 EUR +11.91% Intraday chart for SHORT MINI-FUTURE - MODERNA
Current month+5.97%
1 month-14.11%
Date Price Change
24-06-14 6.39 +11.91%
24-06-13 5.71 +6.33%
24-06-12 5.37 -2.36%
24-06-11 5.5 -0.54%
24-06-10 5.53 +6.55%

Delayed Quote Deutsche Boerse AG

Last update June 14, 2024 at 01:53 pm EDT

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellPUT
Underlying MODERNA, INC.
IssuerLogo Issuer Vontobel Vontobel
WKN VU2UX3
ISINDE000VU2UX38
Date issued 2023-01-30
Strike 207.1 $
Maturity Unlimited
Parity 10 : 1
Emission price 1.47
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 12.9
Lowest since issue 2.14

Company Profile

Moderna, Inc. is a biotechnology company specialized in research and development of therapeutics and vaccines for cancer, infectious, autoimmune and cardiovascular diseases. Net sales break down by type of revenue as follows: - revenue from product sales (95.7%) ; - revenues from grants (4%); - revenues from collaboration agreements (0.3%). At the end of 2021, the group possessed a portfolio of 15 products in clinical development, of which 3 in phase III, 8 in phase II and 4 in phase I, and 12 products in preclinical development. Net sales are distributed geographically as follows: the United States (33.4%), Europe (37.1%) and other (29.5%).
Sector
-
More about the company

Ratings for Moderna, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Moderna, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
140 USD
Average target price
145.2 USD
Spread / Average Target
+3.67%
Consensus